| Single-cell analysis reveals transcriptomic remodellings in distinct cell types that contribute to human prostate cancer progression S Chen, G Zhu, Y Yang, F Wang, YT Xiao, N Zhang, X Bian, Y Zhu, Y Yu, ... Nature cell biology 23 (1), 87-98, 2021 | 312 | 2021 |
| Pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome JVA Franco, T Turk, JH Jung, YT Xiao, S Iakhno, FI Tirapegui, V Garrote, ... Cochrane Database of Systematic Reviews, 2019 | 217 | 2019 |
| Microvesicles and chemokines in tumor microenvironment: mediators of intercellular communications in tumor progression X Bian, YT Xiao, T Wu, M Yao, L Du, S Ren, J Wang Molecular cancer 18 (1), 50, 2019 | 140 | 2019 |
| Targeting signaling pathways in prostate cancer: mechanisms and clinical trials Y He, W Xu, YT Xiao, H Huang, D Gu, S Ren Signal transduction and targeted therapy 7 (1), 198, 2022 | 132 | 2022 |
| Sex differences in severity and mortality among patients with COVID-19: evidence from pooled literature analysis and insights from integrated bioinformatic analysis X Wei, YT Xiao, J Wang, R Chen, W Zhang, Y Yang, D Lv, C Qin, D Gu, ... arXiv preprint arXiv:2003.13547, 2020 | 101 | 2020 |
| Non‐pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome: a Cochrane systematic review JVA Franco, T Turk, JH Jung, YT Xiao, S Iakhno, V Garrote, V Vietto Bju International 124 (2), 197-208, 2019 | 83 | 2019 |
| FOXA1 overexpression suppresses interferon signaling and immune response in cancer Y He, L Wang, T Wei, YT Xiao, H Sheng, H Su, DP Hollern, X Zhang, J Ma, ... The Journal of clinical investigation 131 (14), 2021 | 69 | 2021 |
| Pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome: a Cochrane systematic review JVA Franco, T Turk, JH Jung, YT Xiao, S Iakhno, FI Tirapegui, V Garrote, ... BJU international 125 (4), 490-496, 2020 | 68 | 2020 |
| Single-cell analysis reveals EP4 as a target for restoring T-cell infiltration and sensitizing prostate cancer to immunotherapy S Peng, P Hu, YT Xiao, W Lu, D Guo, S Hu, J Xie, M Wang, W Yu, J Yang, ... Clinical Cancer Research 28 (3), 552-567, 2022 | 52 | 2022 |
| LINC00675 activates androgen receptor axis signaling pathway to promote castration-resistant prostate cancer progression M Yao, X Shi, Y Li, Y Xiao, W Butler, Y Huang, L Du, T Wu, X Bian, G Shi, ... Cell death & disease 11 (8), 638, 2020 | 33 | 2020 |
| An acetyl-histone vulnerability in PI3K/AKT inhibition-resistant cancers is targetable by both BET and HDAC inhibitors D Wu, Y Yan, T Wei, Z Ye, Y Xiao, Y Pan, JJ Orme, D Wang, L Wang, ... Cell reports 34 (7), 2021 | 32 | 2021 |
| Advances in landscape and related therapeutic targets of the prostate tumor microenvironment: Therapeutic targets of the prostate tumor microenvironment D Li, W Xu, Y Chang, Y Xiao, Y He, S Ren Acta Biochimica et Biophysica Sinica 55 (6), 956, 2023 | 16 | 2023 |
| Robotic perineal radical prostatectomy: initial experience with the da Vinci Si robotic system Y Chang, W Xu, X Lu, Y Zhou, M Ji, YT Xiao, Y Sun, S Ren Urologia Internationalis 104 (9-10), 710-715, 2020 | 15 | 2020 |
| Initial experience on extraperitoneal single-port robotic-assisted radical prostatectomy YF Chang, D Gu, N Mei, WD Xu, XJ Lu, YT Xiao, CL Xu, YH Sun, SC Ren Chinese Medical Journal 134 (02), 231-233, 2021 | 14 | 2021 |
| Standardised residency training: students' concerns YT Xiao, YT Wang The Lancet 389 (10072), 905, 2017 | 11 | 2017 |
| Neoadjuvant radiohormonal therapy for oligo-metastatic prostate cancer: safety and efficacy outcomes from an open-label, dose-escalation, single-center, phase I/II clinical trial Y Chang, X Zhao, Y Xiao, S Yan, W Xu, Y Wang, H Zhang, S Ren Frontiers of Medicine 17 (2), 231-239, 2023 | 6 | 2023 |
| Assessing the safety and feasibility of neoadjuvant hormone and radiation therapy followed by robot-assisted radical prostatectomy for treating locally advanced prostate cancer … YT Xiao, X Zhao, Y Chang, X Lu, Y Wang, H Zhang, S Ren BMJ open 10 (11), e038678, 2020 | 5 | 2020 |
| Super-veil nerve-sparing extraperitoneal pure single-port robotic-assisted radical prostatectomy on da Vinci Si robotic system Y Chang, W Xu, Y Xiao, Y Wang, S Yan, S Ren World Journal of Urology 40 (6), 1413-1418, 2022 | 3 | 2022 |
| Utilizing Ubiquitination Patterns to Predict Prostate Cancer Prognosis and Devise a Therapeutic Response. X Zhang, Y Wang, Y Chang, J Wang, S Yan, Y Xiao, T Guo, Y Lou, J Ma, ... Archivos Espanoles de Urologia 76 (3), 215-231, 2023 | 2 | 2023 |
| Integrative analysis of transcriptomic landscape and urinary signature reveals prognostic biomarkers for clear cell renal cell carcinoma W Zhang, W Liu, Y Yang, C Xiao, Y Xiao, X Tan, Q Pang, H Wu, M Hua, ... Frontiers in Oncology 13, 1102623, 2023 | 2 | 2023 |
